CVI Holdings’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

CVI Holdings’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,863	Closed	-$3K	–	937
2022 Q2	$3K	Hold	37,863	–	–	﹤0.01%	901
2022 Q1	$7K	Sell	37,863 -3,803	-9%	-$1.65K	﹤0.01%	900
2021 Q4	$24K	Hold	41,666	–	–	﹤0.01%	872
2021 Q3	$26K	Hold	41,666	–	–	﹤0.01%	828
2021 Q2	$46K	Hold	41,666	–	–	﹤0.01%	707
2021 Q1	$37K	Buy	+41,666	New	+$70.5K	﹤0.01%	573

Other funds holding FLACW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

ETH

Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return

CVI Holdings's FLACW Position: Q3 2022 in Review

CVI Holdings sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q3 2022, closing a stake of 37,863 shares — an estimated $3K sold.

CVI Holdings first reported a position in FLACW in Q1 2021 and held it in 6 quarters. The position peaked at $46K in Q2 2021. 21 funds tracked by Wall St. Rank hold FLACW as of Q3 2022.

CVI Holdings reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q3 2022 after selling out during the quarter.
CVI Holdings sold 37,863 Frazier Lifesciences Acquisition Corporation Warrant shares in Q3 2022, an estimated $3K.
CVI Holdings first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 6 quarters.
CVI Holdings's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $46K in Q2 2021.
21 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q3 2022.

Based on CVI Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.